{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:33:50Z","timestamp":1758944030409},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/leu.2012.193","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T08:04:06Z","timestamp":1342166646000},"page":"489-490","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis"],"prefix":"10.1038","volume":"27","author":[{"given":"D B","family":"Watkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T P","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D L","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"key":"BFleu2012193_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/leu.2010.298","volume":"25","author":"V Grossmann","year":"2011","unstructured":"Grossmann V, Kohlmann A, Zenger M, Schindela S, Eder C, Weissmann S et al. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia 2011; 25: 557\u2013560.","journal-title":"Leukemia"},{"key":"BFleu2012193_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11899-012-0114-5","volume":"7","author":"T Skorski","year":"2012","unstructured":"Skorski T . Genetic mechanisms of chronic myeloid leukemia blastic transformation. Curr Hematol Malig Rep 2012; 7: 87\u201393.","journal-title":"Curr Hematol Malig Rep"},{"key":"BFleu2012193_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079\u20131089.","journal-title":"N Engl J Med"},{"key":"BFleu2012193_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254\u2013266.","journal-title":"N Engl J Med"},{"key":"BFleu2012193_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/leu.2011.280","volume":"26","author":"G Georgiou","year":"2012","unstructured":"Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou MK, Vassilakopoulos TP et al. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. Leukemia 2012; 26: 824\u2013826.","journal-title":"Leukemia"},{"issue":"1","key":"BFleu2012193_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/10428194.2012.701739","volume":"54","author":"Sergej Konoplev","year":"2012","unstructured":"Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M et al. Molecular characterization of de novo Ph+ acute myeloid leukemia. Leuk Lymphoma. e-pub ahead of print 9 July 2012; doi:10.3109\/10428194.2012.701739.","journal-title":"Leukemia & Lymphoma"},{"key":"BFleu2012193_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/leu.2009.95","volume":"23","author":"PP Piccaluga","year":"2009","unstructured":"Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S, Salmi F et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 2009; 23: 1370\u20131371.","journal-title":"Leukemia"},{"key":"BFleu2012193_CR8","first-page":"1147","volume":"91","author":"Y Oki","year":"2006","unstructured":"Oki Y, Jelinek J, Beran M, Verstovsek S, Kantarjian HM, Issa JP . Mutations and promoter methylation status of NPM1 in myeloproliferative disorders. Haematologica 2006; 91: 1147\u20131148.","journal-title":"Haematologica"},{"key":"BFleu2012193_CR9","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1200\/JCO.2009.26.5819","volume":"28","author":"DL White","year":"2010","unstructured":"White DL, Dang P, Engler J, Frede A, Zrim S, Osborn M et al. Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib. J Clin Oncol 2010; 28: 2761\u20132767.","journal-title":"J Clin Oncol"},{"key":"BFleu2012193_CR10","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/sj.leu.2404331","volume":"20","author":"LI Lin","year":"2006","unstructured":"Lin LI, Lin TC, Chou WC, Tang JL, Lin DT, Tien HF . A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias. Leukemia 2006; 20: 1899\u20131903.","journal-title":"Leukemia"},{"key":"BFleu2012193_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.leukres.2008.09.021","volume":"33","author":"P Dvorak","year":"2009","unstructured":"Dvorak P, Hruba M, Subrt I . Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia. Leuk Res 2009; 33: 860\u2013861.","journal-title":"Leuk Res"},{"key":"BFleu2012193_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ajh.21230","volume":"83","author":"C Fava","year":"2008","unstructured":"Fava C, Cortes J . Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia. Am J Hematol 2008; 83: 755.","journal-title":"Am J Hematol"},{"key":"BFleu2012193_CR13","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","volume":"108","author":"C Kovitz","year":"2006","unstructured":"Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J . Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 2006; 108: 2811\u20132813.","journal-title":"Blood"},{"key":"BFleu2012193_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.leukres.2007.01.022","volume":"31","author":"A Pawarode","year":"2007","unstructured":"Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR . Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities. Leuk Res 2007; 31: 1589\u20131592.","journal-title":"Leuk Res"},{"key":"BFleu2012193_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cancergencyto.2008.09.016","volume":"189","author":"P Schafhausen","year":"2009","unstructured":"Schafhausen P, Dierlamm J, Bokemeyer C, Bruemmendorf TH, Bacher U, Zander AR et al. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib. Cancer Genet Cytogenet 2009; 189: 63\u201367.","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012193","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:25:33Z","timestamp":1648740333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,13]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFleu2012193"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.193","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,13]]},"assertion":[{"value":"13 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}